The Valley Desk

NCT02492711 · Interventional trial

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

Overall registry status Completed

Phase 3

Conditions HER-2 Positive Breast Cancer, Metastatic Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov